Table 5.
Control oil | Menhaden oil | s.e.m. | P-value | |
---|---|---|---|---|
Phosphatidylcholine | ||||
14: 0 | 0.5 | 0.4 | 0.2 | ns |
16: 0 | 27.3 | 27.7 | 0.5 | ns |
16: 1 n–7 | 0.4 | 0.9 | 0.2 | 0.04 |
18: 0 | 5.6 | 5.7 | 0.4 | ns |
18: 1 | 10.3 | 9.3 | 0.6 | ns |
18: 2 n–6 | 39.4 | 24.9 | 1.9 | < 0.01 |
18: 3 n–3 | 0.7 | 1.2 | 0.1 | < 0.01 |
20: 3 n–6 | 1.1 | 1.4 | 0.1 | 0.03 |
20: 4 n–6 | 4.2 | 5.8 | 0.5 | < 0.01 |
20: 5 n–3 | 7.6 | 17.7 | 1.6 | < 0.01 |
22: 5 n–3 | 1.7 | 1.8 | 0.2 | ns |
22: 6 n–3 | 1.2 | 3.3 | 0.2 | < 0.01 |
Phosphatidylethanolamine | ||||
14: 0 | nd | nd | ||
16: 0 | 3.7 | 3.6 | 0.5 | ns |
16: 1 n–7 | nd | nd | ||
18: 0 | 22.7 | 24.6 | 0.8 | ns |
18: 1 | 8.6 | 6.3 | 0.6 | 0.01 |
18: 2 n–6 | 19.1 | 11.1 | 1.7 | < 0.01 |
18: 3 n–3 | nd | nd | ||
20: 3 n–6 | 1.4 | 0.8 | 0.3 | 0.04 |
20: 4 n–6 | 14.9 | 14.1 | 0.7 | ns |
20: 5 n–3 | 19.9 | 26.1 | 2.9 | 0.07 |
22: 5 n–3 | 6.2 | 4.4 | 0.4 | 0.02 |
22: 6 n–3 | 4.1 | 8.5 | 0.6 | 0.01 |
Phosphatidylinositol | ||||
14: 0 | nd | nd | ||
16: 0 | 4.4 | 6.6 | 0.6 | 0.02 |
16: 1 n–7 | nd | nd | ||
18: 0 | 47.5 | 43.4 | 1.3 | 0.05 |
18: 1 | 9.7 | 9.9 | 0.6 | ns |
18: 2 n–6 | 11.9 | 8.5 | 0.9 | 0.03 |
18: 3 n–3 | nd | nd | ||
20: 3 n–6 | 2.9 | 3.0 | 0.4 | ns |
20: 4 n–6 | 10.2 | 9.9 | 0.4 | ns |
20: 5 n–3 | 7.7 | 9.6 | 1.1 | 0.09 |
22: 5 n–3 | 4.0 | 5.4 | 0.4 | 0.03 |
22: 6 n–3 | 1.9 | 3.6 | 0.3 | < 0.01 |
Phosphatidylserine | ||||
14: 0 | nd | nd | ||
16: 0 | 8.1 | 5.7 | 1.0 | ns |
16: 1 n–7 | nd | nd | ||
18: 0 | 47.3 | 45.8 | 1.9 | ns |
18: 1 | 15.9 | 14.3 | 1.6 | ns |
18: 2 n–6 | 17.8 | 10.1 | 1.1 | < 0.01 |
18: 3 n–3 | nd | nd | ||
20: 3 n–6 | 1.7 | 2.1 | 0.6 | ns |
20: 4 n–6 | 3.5 | 4.1 | 0.9 | ns |
20: 5 n–3 | 1.1 | 3.7 | 0.6 | 0.01 |
22: 5 n–3 | 2.7 | 6.2 | 0.6 | < 0.01 |
22: 6 n–3 | 1.9 | 8.0 | 0.6 | < 0.01 |
Least square means ±s.e.m.; n = 9 observations per treatment resulting from testing 2 treatments over 3 experimental periods in 6 steers according to a switchback design; nd = not detected; ns, not significant.